Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.

• Authors: Scott R Goldsmith, Michael Slade, John F DiPersio, Peter Westervelt, Steven J Lawrence, Geoffrey L Uy, Camille N Abboud, Ravi Vij, Mark A Schroeder, Todd A Fehniger, Erik R Dubberke, Kathryn Trinkaus, Rizwan Romee
• Journal: Haematologica (Haematologica) Vol. 101 Issue 11 Pg. e465-e468 (11 2016) ISSN: 1592-8721 [Electronic] Italy
• PMID: 27443287 (Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• Cyclophosphamide

Topics

• Cyclophosphamide (therapeutic use)
• Cytomegalovirus
• Cytomegalovirus Infections
• Graft vs Host Disease (drug therapy, prevention & control)
• Humans
• Leukemia, Myeloid (complications, mortality, therapy)
• Peripheral Blood Stem Cell Transplantation (adverse effects, methods)
• Recurrence
• T-Lymphocytes
• Transplantation, Haploidentical (adverse effects, methods)
• Viremia